Walana

Company Overview

Snapshot

Founded in March 2015 by Markus Glimm and Gil Gat, Walana operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its core technology.

Business overview

Walana is a Health Tech & Life Sciences company focused on transforming patient interaction with pharmaceutical companies and healthcare providers through specialized healthcare chatbots. Its core product, ViTUS, is an AI-powered chatbot designed to collect and analyze wellness and symptom data, identify patterns, and create personalized plans for patients. ViTUS also provides real-time data to physicians for tailored treatments. Walana serves patients, pharmaceutical companies, and healthcare providers by leveraging big data analytics to facilitate better decision-making in digital healthcare, operating in markets such as China, South Korea, Japan, and Singapore.

Company Intelligence Q&A

What is Walana's primary focus?

Walana aims to change how patients interact with pharmaceutical companies and healthcare providers by using specialized healthcare chatbots combined with human communication.

What is ViTUS?

ViTUS is a chatbot developed by Walana that collects and analyzes wellness and symptom-related data, identifies patterns and correlations, and then creates plans and tools to help patients with their daily functions.

How does Walana assist physicians?

Walana's ViTUS chatbot provides real-time data to help physicians better tailor their treatments for patients.

What kind of data does Walana analyze?

Walana analyzes millions of pieces of data to help patients, pharmaceutical companies, and healthcare providers make more informed decisions.

Who are the founders of Walana?

Walana was co-founded by Markus Glimm, who serves as CEO, and Gil Gat.